Bristol-Myers Squibb Co (NYSE: BMY)

DRUGS - Drug Manufacturers - Major
Sector: Health Care

Stock price data as of 04/12/2024

Closing price: 48.28

Support price level:	$47.86
Resistance price level:	$52.55
Relative strength index (14-day RSI)	30.3
Beta	0.37

BMY is at or near its 52-week low. Though contrarian gains may be possible, the risk of further declines is considerable.
With a -31.2 percent return in the past year, this stock is among the worst 10 percent of performers in the S&P-100.
Down 5.9 percent, BMY is one of this week's biggest decliners.
The price of this low-beta stock is expected to increase by 0.37% for every 1% increase in the S&P-500.
Volatility is forecast to fall over the next month.

Low	High	Price as % of Range
$47.98	$70.60	1.6%

200 day	50 day	20 day	10 day
$54.89	$51.15	$51.72	$51.10

(Annualized standard deviation)

Historical (5 year)	Last month	Current estimate	Next month forecast
22.1%	22.9%	24.3%	22.9%

There is an estimated 5% probability that the stock price of Bristol-Myers Squibb Co will fall by more than: